Drawing for DESIGN-BUILD-TEST-LEARN

USPTO serial 86402834

DESIGN-BUILD-TEST-LEARN

Reviewed by CopyMark Law Group

Reg. 5124761Status 710
Filing date
Status date
Registration date
Jan 17, 2017
Examiner
MARTIN, LIEF ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DESIGN-BUILD-TEST-LEARN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Doyle Siever

Doyle Siever Precigen, Inc.20374 Seneca Meadows ParkwayGermantown, MD 20876UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Development of new technology for others in the fields of medicine, genetics, therapeutics, biotechnology, agriculture, energy, fuels, biofuels, biochemistry, the chemical industry, and the environment; research and development of environmentally friendly forms of energy and power; development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize cell function or disease states; research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; scientific research and product development services for others in the pharmaceutical, chemical, biochemical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; providing temporary use of non-downloadable computer software for storing, managing, modifying, sharing, and synthesizing data for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; providing temporary use of non-downloadable computer software for creating databases and for web-based research for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; providing temporary use of non-downloadable computer software for storing, managing, modifying, sharing, and synthesizing data for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; providing temporary use of non-downloadable computer software for creating databases and for web-based research for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; computer services, namely, providing an interactive web site featuring technology that allows users to view, store, and manage data for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnologySECTION 8 - CANCELLEDFeb 10, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 7, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 7, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 28, 2023C8..CANCELLED SEC. 8 (6-YR)—
Jan 17, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 9, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Apr 16, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 16, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 16, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 16, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 8, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 17, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 10, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 9, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 9, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 9, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 9, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 9, 2016SNEASU-EXAMINER'S AMENDMENT WRITTEN—
Nov 17, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 16, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 16, 2016EX2GSOU EXTENSION 2 GRANTED—
Nov 3, 2016IUAFUSE AMENDMENT FILED—
Nov 3, 2016EXT2SOU EXTENSION 2 FILED—
Nov 3, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 3, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 3, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 18, 2016PCGRPETITION TO DIRECTOR GRANTED—
Jul 14, 2016APETASSIGNED TO PETITION STAFF—
Jul 8, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 7, 2016EX1GSOU EXTENSION 1 GRANTED—
Jul 5, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 3, 2016EXT1SOU EXTENSION 1 FILED—
Jun 3, 2016TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Jun 3, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 8, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 13, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 13, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 4, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 4, 2015ALIEASSIGNED TO LIE—
Aug 17, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 17, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Aug 17, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 17, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 17, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 20, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 20, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 20, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 27, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 26, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 2, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2015DOCKASSIGNED TO EXAMINER—
Sep 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance